Copyright
©The Author(s) 2023.
World J Gastroenterol. Jul 7, 2023; 29(25): 3964-3983
Published online Jul 7, 2023. doi: 10.3748/wjg.v29.i25.3964
Published online Jul 7, 2023. doi: 10.3748/wjg.v29.i25.3964
Figure 2 Hepatitis B virus antiviral treatment history.
The figure shows the United States Food and Drug Administration approval dates for hepatitis B virus drugs. IFN: Interferon; Peg-IFN: Pegylated interferon; LAM: Lamivudine; ADV: Adefovir; TDF: Tenofovir; ETV: Entecavir; LdT: Telbivudine; TAF: Tenofovir alafenamide.
- Citation: Broquetas T, Carrión JA. Past, present, and future of long-term treatment for hepatitis B virus. World J Gastroenterol 2023; 29(25): 3964-3983
- URL: https://www.wjgnet.com/1007-9327/full/v29/i25/3964.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i25.3964